We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-0.03%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.2B
AUM Growth
+$10.2B
Cap. Flow
+$1.69B
Cap. Flow %
16.49%
Top 10 Hldgs %
49.38%
Holding
721
New
55
Increased
105
Reduced
258
Closed
39

Sector Composition

Rank Sector Weight
1 Energy 67.58%
2 Financials 2.55%
3 Healthcare 2.33%
4 Materials 1.85%
5 Technology 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WELL icon
151
Welltower
WELL
$178B
$2.93M 0.03%
43,074
-1,245
-3% -$81.3K
HALO icon
152
Halozyme
HALO
$9.72B
$2.92M 0.03%
168,639
-30,553
-15% -$487K
WMB icon
153
Williams Companies
WMB
$90.5B
$2.92M 0.03%
113,510
+26,151
+30% +$914K
NG icon
154
NovaGold Resources
NG
$2.6B
$2.9M 0.03%
689,172
-134,655
-16% -$517K
ET icon
155
Energy Transfer Partners
ET
$70.1B
$2.89M 0.03%
210,476
+67,269
+47% +$1.26M
PLD icon
156
Prologis
PLD
$138B
$2.75M 0.03%
64,105
-2,108
-3% -$88.9K
PPP
157
DELISTED
Primero Mining Corp
PPP
$2.73M 0.03%
1,196,161
+15,710
+1% +$37.6K
SAND
158
DELISTED
Sandstorm Gold
SAND
$2.6M 0.03%
987,421
-70,777
-7% -$194K
KGC icon
159
Kinross Gold
KGC
$28.5B
$2.5M 0.02%
1,374,281
-981,061
-42% -$1.94M
IWP icon
160
iShares Russell Mid-Cap Growth ETF
IWP
$20B
$2.47M 0.02%
53,806
+45,354
+537% +$2.11M
KYNB
161
Kyntra Bio
KYNB
$28.5M
$2.46M 0.02%
3,232
-479
-13% -$318K
ACOR
162
DELISTED
Acorda Therapeutics
ACOR
$2.43M 0.02%
474
-85
-15% -$371K
BXP icon
163
Boston Properties
BXP
$11B
$2.4M 0.02%
18,839
-612
-3% -$76.2K
SIOX
164
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2.35M 0.02%
+16,327
New +$2.12M
KDNY
165
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.34M 0.02%
16,657
-2,826
-15% -$384K
DBVT
166
DBV Technologies
DBVT
$807M
$2.31M 0.02%
+6,351
New +$2.22M
VTR icon
167
Ventas
VTR
$48.9B
$2.29M 0.02%
40,660
-1,293
-3% -$70.4K
EQIX icon
168
Equinix
EQIX
$107B
$2.28M 0.02%
+7,543
New +$2.2M
SAGE
169
DELISTED
Sage Therapeutics
SAGE
$2.22M 0.02%
38,021
-6,380
-14% -$316K
DOC icon
170
Healthpeak Properties
DOC
$15.4B
$2.17M 0.02%
62,438
-1,803
-3% -$60.3K
VNO icon
171
Vornado Realty Trust
VNO
$7.47B
$2.16M 0.02%
26,690
-712
-3% -$56.2K
XLRN
172
DELISTED
Acceleron Pharma
XLRN
$2.14M 0.02%
43,805
-7,942
-15% -$286K
PAGP icon
173
Plains GP Holdings
PAGP
$5.23B
$2.12M 0.02%
84,378
+34,268
+68% +$1.2M
MON
174
DELISTED
Monsanto Co
MON
$2.09M 0.02%
21,170
-7,474
-26% -$702K
EBS icon
175
Emergent Biosolutions
EBS
$375M
$2.05M 0.02%
51,300
-9,432
-16% -$329K

Similar funds

ALPS Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, ALPS Advisors held 721 positions worth $10.2B, up 10,697% from $94.9M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

ALPS Advisors deployed $1.69B of net new capital in Q4 2015, opening 55 new positions and adding to 105 existing holdings. Its largest new stake was MPLX: 16,812,418 shares worth $661M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, down from 68% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Williams Partners L.P., an estimated $50.1M trimmed.

  • ALPS Advisors's largest Q4 2015 buy was MPLX: 16,812,418 shares worth $661M.
  • ALPS Advisors added most to Buckeye Partners, L.P. in Q4 2015, an estimated $192M increase.
  • ALPS Advisors's biggest Q4 2015 reduction was Williams Partners L.P., cutting an estimated $50.1M.
  • ALPS Advisors fully exited MARKWEST ENERGY PARTNERS, LP in Q4 2015, selling an estimated $4.85M.
  • ALPS Advisors's ten largest holdings make up 49% of its $10.2B portfolio in Q4 2015.
  • ALPS Advisors opened 55 new positions and closed 39 in Q4 2015.
  • ALPS Advisors's portfolio value rose 10,697% quarter-over-quarter to $10.2B.

Based on ALPS Advisors's 13F filing for Q4 2015, filed 5 Feb 2016.